Unknown

Dataset Information

Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.


ABSTRACT:

Background

Targeting low-dose computed tomography (LDCT) for lung cancer screening to persons at highest risk for lung cancer mortality has been suggested to improve screening efficiency.

Objective

To quantify the value of risk-targeted selection for lung cancer screening compared with National Lung Screening Trial (NLST) eligibility criteria.

Design

Cost-effectiveness analysis using a multistate prediction model.

Data sources

NLST.

Target population

Current and former smokers eligible for lung cancer screening.

Time horizon

Lifetime.

Perspective

Health care sector.

Intervention

Risk-targeted versus NLST-based screening.

Outcome measures

Incremental 7-year mortality, life expectancy, quality-adjusted life-years (QALYs), costs,

SUBMITTER: Kumar V 

PROVIDER: S-EPMC6533918 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature